368 related articles for article (PubMed ID: 9419974)
21. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
22. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
Tutter AV; Fryer CJ; Jones KA
Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
[TBL] [Abstract][Full Text] [Related]
23. [beta-catenin].
Ogawa K; Yaginuma Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():161-6. PubMed ID: 11761935
[No Abstract] [Full Text] [Related]
24. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.
Hovanes K; Li TW; Munguia JE; Truong T; Milovanovic T; Lawrence Marsh J; Holcombe RF; Waterman ML
Nat Genet; 2001 May; 28(1):53-7. PubMed ID: 11326276
[TBL] [Abstract][Full Text] [Related]
25. Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification.
Geng X; Xiao L; Lin GF; Hu R; Wang JH; Rupp RA; Ding X
FEBS Lett; 2003 Jul; 547(1-3):1-6. PubMed ID: 12860376
[TBL] [Abstract][Full Text] [Related]
26. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
27. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
Novak A; Hsu SC; Leung-Hagesteijn C; Radeva G; Papkoff J; Montesano R; Roskelley C; Grosschedl R; Dedhar S
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4374-9. PubMed ID: 9539744
[TBL] [Abstract][Full Text] [Related]
28. A possible role for the WNT-1 pathway in oral carcinogenesis.
Lo Muzio L
Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525
[TBL] [Abstract][Full Text] [Related]
29. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
30. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
[TBL] [Abstract][Full Text] [Related]
31. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
Ishitani T; Ninomiya-Tsuji J; Matsumoto K
Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
[TBL] [Abstract][Full Text] [Related]
32. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
Hsu SC; Galceran J; Grosschedl R
Mol Cell Biol; 1998 Aug; 18(8):4807-18. PubMed ID: 9671490
[TBL] [Abstract][Full Text] [Related]
33. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
Kolligs FT; Hu G; Dang CV; Fearon ER
Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
[TBL] [Abstract][Full Text] [Related]
36. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
37. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression.
Gradl D; Kühl M; Wedlich D
Mol Cell Biol; 1999 Aug; 19(8):5576-87. PubMed ID: 10409747
[TBL] [Abstract][Full Text] [Related]
38. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
39. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
[TBL] [Abstract][Full Text] [Related]
40. CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury.
Surendran K; Simon TC
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F653-62. PubMed ID: 12475749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]